13F-HR filed by Bpifrance SA
Bpifrance SA filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-13, with 7 holding rows worth $3,960,743,000.
- Accession
- 0001104659-21-066015
- Filer
- CIK 1731118
- Filed
- 2021-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 7 entries on the cover page, a total value of $3,960,743,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,960,743,000 with VALUE read as thousands by filing date, 13F file number 028-19626. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBpifrance Participations SA028-19623
- included managerInternal server error. CIK may be invalid.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| STELLANTIS N.V SHS | N82405106 | Stock | 192,703,907 | $3,407,256,000 | thousands by filing date | |
| CONSTELLIUM NV-CLASS A | N22035104 | CL A | 16,393,903 | $240,990,000 | thousands by filing date | |
| TECHNIPFMC PLC COM | G87110105 | Stock | 24,688,691 | $188,564,000 | thousands by filing date | |
| CRITEO S A SPONS ADS | 226718104 | ADR | 2,718,752 | $94,422,000 | thousands by filing date | |
| SEQUANS COMMUNICATIONS SA | 817323108 | COM | 3,300,018 | $19,932,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 425,726 | $8,604,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 8,000 | $975,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-066015 | this filing | 2021-05-13 | acceptance time not in the bulk data set |